Approval · Notice of Compliance 931 · 2003
GLIC: Notice of Compliance 931
Issued October 2, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 931
- Date
- October 2, 2003
- Company
- Prempharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Oral hypoglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLIC | 02248210 | Cancelled Post Market |
Medicinal ingredients
- GLICLAZIDE 80 MG per TAB